Asthma and Chronic Obstructive Pulmonary Disease
暂无分享,去创建一个
[1] M. R. Siddiqui,et al. Global Initiative for Chronic Obstructive Lung Disease (GOLD) , 2017 .
[2] D. Postma,et al. Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review. , 2013, The Journal of allergy and clinical immunology.
[3] D. Postma,et al. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study , 2013, Respiratory Research.
[4] D. Postma,et al. Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma , 2013, Allergy.
[5] E. R. Sutherland,et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. , 2012, American journal of respiratory and critical care medicine.
[6] J. Hogg,et al. Mast cell infiltration discriminates between histopathological phenotypes of chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.
[7] David C. Nickle,et al. Lung eQTLs to Help Reveal the Molecular Underpinnings of Asthma , 2012, PLoS genetics.
[8] D. Sin,et al. Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis , 2012, International journal of chronic obstructive pulmonary disease.
[9] Y. Bossé,et al. Updates on the COPD gene list , 2012, International journal of chronic obstructive pulmonary disease.
[10] P. Berger,et al. Airway smooth muscle in asthma: just a target for bronchodilation? , 2012, Clinics in chest medicine.
[11] J. Soriano,et al. Consensus document on the overlap phenotype COPD-asthma in COPD. , 2012, Archivos de bronconeumologia.
[12] M. Saetta,et al. Pathophysiology of the Small Airways in Chronic Obstructive Pulmonary Disease , 2012, Respiration.
[13] Christopher E Brightling,et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. , 2012, American journal of respiratory and critical care medicine.
[14] Yusuke Nakamura,et al. Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene , 2012, PLoS genetics.
[15] L. Edwards,et al. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease , 2012, Thorax.
[16] D. Postma,et al. Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD , 2012, European Respiratory Journal.
[17] R. Hancox,et al. Asthma phenotypes: Consistency of classification using induced sputum , 2012, Respirology.
[18] Kathleen M. Akgün,et al. Epidemiology and management of common pulmonary diseases in older persons. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.
[19] B. Celli,et al. Bronchodilator reversibility in COPD. , 2011, Chest.
[20] Joyce D. Schroeder,et al. The clinical features of the overlap between COPD and asthma , 2011, Respiratory research.
[21] D. Postma,et al. I have taken my umbrella, so of course it does not rain , 2011, Thorax.
[22] D. Postma,et al. Asthma and chronic obstructive pulmonary disease: common genes, common environments? , 2011, American journal of respiratory and critical care medicine.
[23] C. Salome,et al. Predictors of airway hyperresponsiveness differ between old and young patients with asthma. , 2011, Chest.
[24] Bram van Ginneken,et al. CT-quantified emphysema in male heavy smokers: association with lung function decline , 2011, Thorax.
[25] T. Haahtela,et al. Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.
[26] D. Postma,et al. Small airway disease in asthma and COPD: clinical implications. , 2011, Chest.
[27] D. Postma,et al. Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1). , 2010, Respiratory medicine.
[28] L. Fabbri,et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. , 2010, The Journal of allergy and clinical immunology.
[29] N. Pride,et al. Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease , 2010, Thorax.
[30] D. Postma,et al. Airway epithelial changes in smokers but not in ex-smokers with asthma. , 2009, American journal of respiratory and critical care medicine.
[31] D. Postma,et al. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. , 2009, Annals of internal medicine.
[32] T. Welte,et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.
[33] P. Gibson,et al. The overlap syndrome of asthma and COPD: what are its features and how important is it? , 2009, Thorax.
[34] C. Kroegel. Global Initiative for Asthma (GINA) guidelines: 15 years of application , 2009, Expert review of clinical immunology.
[35] D. Postma,et al. Maternal smoking during pregnancy induces airway remodelling in mice offspring , 2009, European Respiratory Journal.
[36] M. Weatherall,et al. Distinct clinical phenotypes of airways disease defined by cluster analysis , 2009, European Respiratory Journal.
[37] D. Postma,et al. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation , 2009, International journal of chronic obstructive pulmonary disease.
[38] M. Decramer,et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.
[39] P. Calverley,et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.
[40] Anand A. Dalal,et al. Burden of concomitant asthma and COPD in a Medicaid population. , 2008, Chest.
[41] M. Decramer,et al. Bronchodilator responsiveness in patients with COPD , 2008, European Respiratory Journal.
[42] M. Dolhnikoff,et al. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease , 2008, Current opinion in pulmonary medicine.
[43] I. Pavord,et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. , 2007, Chest.
[44] B. Caldwell,et al. External validity of randomized controlled trials in COPD. , 2007, Respiratory medicine.
[45] I. Pavord,et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial , 2007, European Respiratory Journal.
[46] Sylvia Verbanck,et al. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation , 2007, Thorax.
[47] Richard Beasley,et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? , 2006, Thorax.
[48] K. Rabe,et al. Differential distribution of inflammatory cells in large and small airways in smokers , 2006, Journal of Clinical Pathology.
[49] D. Postma,et al. Predictors of COPD symptoms: does the sex of the patient matter? , 2006, European Respiratory Journal.
[50] C. Brightling,et al. Eosinophilic airway inflammation in COPD , 2006, International journal of chronic obstructive pulmonary disease.
[51] D. Price,et al. International Primary Care Respiratory Group (IPCRG) Guidelines: diagnosis of respiratory diseases in primary care. , 2006, Primary care respiratory journal : journal of the General Practice Airways Group.
[52] D. Postma,et al. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers , 2005, European Respiratory Journal.
[53] N. Thomson,et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma , 2005, Thorax.
[54] I. Pavord,et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease , 2005, Thorax.
[55] S. Guerra. Overlap of asthma and chronic obstructive pulmonary disease , 2005, Current opinion in pulmonary medicine.
[56] L. Grinberg,et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. , 2004, American journal of respiratory and critical care medicine.
[57] Dirkje S Postma,et al. Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. , 2004, Chest.
[58] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[59] D. Rogers. Airway mucus hypersecretion in asthma: an undervalued pathology? , 2004, Current opinion in pharmacology.
[60] Joan B Soriano,et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. , 2003, Chest.
[61] M. Aubier,et al. Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.
[62] M. Paiva,et al. Nonreversible conductive airway ventilation heterogeneity in mild asthma. , 2003, Journal of applied physiology.
[63] D. Postma,et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. , 2003, Thorax.
[64] L. Corbetta,et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[65] A. Buist,et al. Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes , 2003, European Respiratory Journal.
[66] D. Mannino,et al. Characteristics of adults dying with COPD. , 2002, Chest.
[67] L. Palmer,et al. Infants with flow limitation at 4 weeks: outcome at 6 and 11 years. , 2002, American journal of respiratory and critical care medicine.
[68] H. Kauffman,et al. Markers of active airway inflammation and remodelling in chronic obstructive pulmonary disease , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[69] L. Fabbri,et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[70] S. Weiss,et al. Atopy as a risk factor for chronic obstructive pulmonary disease: epidemiological evidence. , 2000, American journal of respiratory and critical care medicine.
[71] C. Jenkins,et al. Optimal asthma control, starting with high doses of inhaled budesonide. , 2000, The European respiratory journal.
[72] D. Postma,et al. Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. , 1999, American journal of respiratory and critical care medicine.
[73] M Paiva,et al. Evidence of acinar airway involvement in asthma. , 1999, American journal of respiratory and critical care medicine.
[74] Dirkje S Postma,et al. Ongoing airway inflammation in patients with COPD who do not currently smoke , 1999, Chest.
[75] D. Postma,et al. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[76] M. Noppen,et al. Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD. , 1998, American journal of respiratory and critical care medicine.
[77] F. Dekker,et al. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: descriptive study , 1998, BMJ.
[78] J. Bousquet,et al. Corticosteroid reversibility in COPD is related to features of asthma. , 1997, American journal of respiratory and critical care medicine.
[79] J. Vestbo,et al. Chronic mucus hypersecretion in COPD and death from pulmonary infection. , 1995, The European respiratory journal.
[80] M. Cosio,et al. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. , 1995, American journal of respiratory and critical care medicine.
[81] D. Postma,et al. Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. The Dutch CNSLD Study Group. , 1995, American journal of respiratory and critical care medicine.
[82] P. Paré,et al. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.
[83] A. James,et al. The structure of large and small airways in nonfatal and fatal asthma. , 1993, The American review of respiratory disease.
[84] D. Postma,et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. , 1992, The New England journal of medicine.
[85] P. Paré,et al. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.
[86] E. Bleecker,et al. The Lung Health Study: Airway Responsiveness to Inhaled Methacholine in Smokers with Mild to Moderate Airflow Limitation , 1992 .
[87] S. Sahn. Corticosteroids in chronic bronchitis and pulmonary emphysema. , 1978, Chest.
[88] T. Kennedy,et al. Effect of aging alone on mechanical properties of the normal adult human lung. , 1977, Journal of applied physiology: respiratory, environmental and exercise physiology.
[89] D. Niewoehner,et al. Pathologic changes in the peripheral airways of young cigarette smokers. , 1974, The New England journal of medicine.
[90] H. Magnussen,et al. Improvements with tiotropium in COPD patients with concomitant asthma. , 2008, Respiratory medicine.
[91] A. B. Kay,et al. Overview of 'allergy and allergic diseases: with a view to the future'. , 2000, British medical bulletin.
[92] A. James,et al. The airway longitudinal elastic fiber network and mucosal folding in patients with asthma. , 2000, American journal of respiratory and critical care medicine.
[93] G. O'Connor,et al. The relation of airways responsiveness and atopy to the development of chronic obstructive lung disease. , 1988, Epidemiologic reviews.